GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway.
## Our four business units
Imaging: Spans the care continuum and provides critical tools for physicians, from initial screening and diagnosis, through therapeutic decision-making and monitoring of patient progression. Our products support providers in the delivery of care including oncology, cardiology, neurology, nuclear medicine, orthopedics, women’s health, and pediatrics.
• Milestone: U.S. Food and Drug Administration (FDA) clearance for state-of-the-art deep learning-based technology that enables magnetic resonance (MR) cardiac imaging within a single heartbeat and can help reduce scan time by up to 83%a).
Advanced Visualization Solutions: Our focus is on designing solutions that are aligned by specialties or care areas for specific clinical workflows to better serve the unique needs of our customers and improve patient outcomes, while lowering the overall cost of care. We continue to deliver innovative ultrasound probes, consoles, and digital and AI solutions that increase diagnostic accuracy and simplify clinical and operational workflows.
• Milestone: Pioneered the first handheld ultrasound in 2010. In 2021, we made it wireless and pocket-sized with crystal clear image quality for whole-body scanning and added intuitive software - all in the palm of clinicians’ hands.
Patient Care Solutions: A leading global provider of medical devices, consumables, services, and digital solutions that acquire and transform complex clinical data into real-time visualization and clinical decision support. Our devices, digital solutions, and service solutions form a broad and integrated portfolio that support patient care needs and care teams within and beyond most acute healthcare environments.
• Milestone: FDA clearance for a first-of-its-kind, wireless monitoring solution aiding early detection of patient deterioration.
Pharmaceutical Diagnostics (PDx): We are a leading supplier of diagnostic agents to the radiology and nuclear medicine industry. Our diagnostic agents help clinicians assess patients to enable more precise diagnoses and better therapy selection. We distribute products globally, providing on-time delivery of quality products that help meet patient and procedural needs across modalities. PDx’s diagnostic agents are complementary to the imaging and ultrasound devices we offer, including computed tomographgy (CT), angiography and X-ray, MR, single-photon emission computed tomography (SPECT) and positron emission tomography (PET), and are also compatible with systems from other equipment vendors.
• Milestone: Introduced the first and only FDA-approved PET agent for color imaging of amyloid plaque now being used to aid in the diagnosis of Alzheimer’s disease in patients with cognitive decline.
## Creating a world where healthcare has no limits
• We are a $19.6 billion business with approximately 51,000 colleagues and included in the S&P 500, Nasdaq-100 and Fortune 500
• We execute on our precision care strategy at the forefront of care delivery across the patient journey, serving 1B+ patients annually and 5M+ installed base equipment
• We play a central role in healthcare digitization with 200+ software apps driving breakthroughs in clinical insights
• We are an industry-defining innovator with 10, 300 engineers and scientists focused on R&D
• We are a leader in an attractive $87B global healthcare market
• We are led by an experienced leadership team with the right strategic vision:
o Peter J. Arduini - President and Chief Executive Officer
o James (Jay) Saccaro - Vice President and Chief Financial Officer
## Our care pathway approach
Our global teams collaborate to deliver products, services and solutions that touch nearly every part of the patient journey across key disease specific states like cardiology, neurology and oncology. We are innovating to help clinicians improve patient outcomes and reduce the time from diagnosis to treatment.
## Innovation
We are a proven innovator with a history of delivering industry firsts to advance the future of healthcare: first full-body CT, commercialization of MR, handheld ultrasound, first and only iso-osmolar contrast medium, first hospital command center, and topping the FDA’s list with the most AI-enabled device authorizations of any medtech company, with 80b). We are developing new capabilities for the future, leveraging AI and machine learning to connect healthcare workflows across operations, data silos, and analytics.
## Trusted partner
Our portfolio of solutions addresses the biggest challenges facing the healthcare industry today, including helping clinicians provide better outcomes, improve operational efficiencies and enhance productivity. These qualities foster trust, loyalty, and partnership with our global customer base in approximately 160 countries.
CdZnTe Association (CdZnTe.com)
https://www.cdznte.com/organization/ge-healthcare.html
